Enhanced enzyme immunoassay with negative-gray-zone testing compared to a single nucleic acid amplification technique for community-based chlamydial screening of men

Journal of Clinical Microbiology

Volumn 43, Issue 5, 2005, Pages 2065-2069

  Horner, Paddy ^a,b   Skidmore, Sue ^c   Herring, Alan ^d   Sell, Jo ^d   Paul, Ian ^d   Caul, Owen ^d   Egger, Matthias ^b   McCarthy, Anne ^b   Sanford, Emma ^b   Salisbury, Chris ^b   MacLeod, John ^e   Sterne, Jonathan ^b   Low, Nicola ^b  

^a UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c PRINCESS ROYAL HOSPITAL   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NUCLEIC ACID AMPLIFICATION; OPTICAL DENSITY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE; TECHNIQUE;

ALGORITHMS; BASE SEQUENCE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COMMUNITY-ACQUIRED INFECTIONS; GENE AMPLIFICATION; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS;

CHLAMYDIA TRACHOMATIS;

EID: 20844438493     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.5.2065-2069.2005     Document Type: Article

References (37)

1. Andersen, B., F. Olesen, J. K. Moller, and L. Ostergaard. 2002. Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial. J. Infect. Dis. 185:252-258.
2. Boom, R., C. J. Sol, M. M. Salimans, C. L. Jansen, P. M. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
3. Caul, E. O., P. J. Horner, J. Leece, T. Crowley, L. Paul, and G. Davey Smith. 1997. Population-based screening programmes for Chlamydia trachomatis. Lancet 349:1070-1071.
4. Centers for Disease Control and Prevention. 1997. Chlamydia trachomatis genital infections-United States, 1995. Morb. Mortal. Wkly. Rep. 46:193-198.
5. Chernesky, M., D. Jang, D. Copes, J. Patel, A. Petrich, K. Biers, A. Sproston, and J. Kapala. 2001. Comparison of a polymer conjugate-enhanced enzyme immunoassay to ligase chain reaction for diagnosis of Chlamydia trachomatis in endocervical swabs. J. Clin. Microbiol. 39:2306-2307.
6. Chernesky, M. A. 2002. Chlamydia trachomatis diagnostics. Sex. Transm. Infect. 78:232-234.
7. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 1999. National guideline for the management of Chlamydia trachomatis genital tract infection. Sex. Transm. Infect. 75(Suppl. 1):S4-S8.
8. Dean, D., D. Ferrero, and M. McCarthy. 1998. Comparison of performance and cost-effectiveness of direct fluorescent-antibody, ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection. J. Clin. Microbiol. 36:94-99.
9. Duncan, B., and G. Hart. 1999. Sexuality and health: the hidden costs of screening for Chlamydia trachomatis. BMJ 318:931-933.
10. Fenton, K. A., C. Korovessis, A. M. Johnson, A. McCadden, S. McManus, K. Wellings, C. H. Mercer, C. Carder, A. J. Copas, K. Nanchahal, W. Macdowall, G. Ridgway, J. Field, and B. Erens. 2001. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 358:1851-1854. (Erratum, 359:174, 2002.)
11. Geisler, W. M., R. J. Suchland, W. L. Whittington, and W. E. Stamm. 2001. Quantitative culture of Chlamydia trachomatis: relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease. J. Infect. Dis. 184:1350-1354.
12. Hadgu, A. 1997. Bias in the evaluation of DNA-amplification tests for detecting Chlamydia trachomatis. Stat. Med. 16:1391-1399.
13. Hart, G. J., B. Duncan, and K. A. Fenton. 2002. Chlamydia screening and sexual health. Sex. Transm. Infect. 78:396-397.
14. Johnson, R. E., T. A. Green, J. Schachter, R. B. Jones, E. W. Hook III, C. M. Black, D. H. Martin, M. E. St. Louis, and W. E. Stamm. 2000. Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J. Clin. Microbiol. 38:4382-4386.
15. Johnson, R. E., W. J. Newhall, J. R. Papp, J. S. Knapp, C. M. Black, T. L. Gift, R. Steece, L. E. Markowitz, O. J. Devine, C. M. Walsh, S. Wang, D. C. Gunter, K. L. Irwin, S. DeLisle, and S. M. Berman. 2002. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections-2002. Morb. Mortal. Wkly. Rep. 51:1-38.
16. Loeffelholz, M. J., C. A. Lewinski, S. R. Silver, A. P. Purohit, S. A. Herman, D. A. Buonagurio, and E. A. Dragon. 1992. Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction. J. Clin. Microbiol. 30:2847-2851.
17. Low, N., A. McCarthy, J. MacLeod, C. Salisbury, P. J. Horner, T. E. Roberts, R. Campbell, A. Herring, S. Skidmore, E. Sanford, J. A. C. Sterne, G. Davey Smith, A. Graham, M. Huengsberg, J. Ross, and M. Egger for the Chlamydia Screening Studies Group. 2004. The Chlamydia screening studies: rationale and design. Sex. Transm. Infect. 80:342-348.
18. Mallinson, H., J. Hopwood, and K. Mutton. 2002. Resolution of the recent performance problem of Abbott LCx Chlamydia trachomatis assay. Issues of repeat testing for confirmation of chlamydial infection. Sex. Transm. Infect. 78:225-226.
19. McAdam, A. J. 2000. Discrepant analysis: how can we test a test? J. Clin. Microbiol. 38:2027-2029.
20. Miller, W. C. 1998. Bias in discrepant analysis: when two wrongs don't make a right. J. Clin. Epidemiol. 51:219-231.
21. Okadome, A., T. Notomi, S. Nomura, and A. Nagayama. 1999. Reactivity of a dual amplified chlamydia immunoassay with different serovars of Chlamydia trachomatis. Int. J. STD AIDS 10:460-463.
22. PHLS, DHSS&PS, and Scottish ISD(D)5 Collaborative Group. 2004. Sexually transmitted infections in the UK: new episodes seen in genitourinary medicine clinics, 1995-2000. Public Health Laboratory Service, London, United Kingdom.
23. Shattock, R. M., C. Patrizio, P. Simmonds, and S. Sutherland. 1998. Detection of Chlamydia trachomatis in genital swabs: comparison of commercial and in house amplification methods with culture. Sex. Transm. Infect. 74:289-293.
24. Smieja, M., J. B. Mahony, C. H. Goldsmith, S. Chong, A. Petrich, and M. Chernesky. 2001. Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens. J. Clin. Microbiol. 39:1796-1801.
25. Sugunendran, H., H. D. Birley, H. Mallinson, M. Abbott, and C. Y. Tong. 2001. Comparison of urine, first and second endourethral swabs for PCR based detection of genital Chlamydia trachomatis infection in male patients. Sex. Transm. Infect. 77:423-426.
26. Tanaka, M., H. Nakayama, K. Sagiyama, M. Haraoka, H. Yoshida, T. Hagiwara, K. Akazawa, and S. Naito. 2000. Evaluation of a new amplified enzyme immunoassay (EIA) for the detection of Chlamydia trachomatis in male urine, female endocervical swab, and patient obtained vaginal swab specimens. J. Clin. Pathol. 53:350-354.
27. Tanaka, M., H. Nakayama, H. Yoshida, K. Takahashi, T. Nagafuji, T. Hagiwara, and J. Kumazawa. 1998. Detection of Chlamydia trachomatis in vaginal specimens from female commercial sex workers using a new improved enzyme immunoassay. Sex. Transm. Infect. 74:435-438.
28. Taylor-Robinson, D., and B. J. Thomas. 2000. Sensitivity of chlamydial diagnostic tests. Int. J. STD AIDS 11:204-205.
29. Templeton, K., J. Roberts, D. Jeffries, G. Forster, and C. Aitken. 2001. The detection of Chlamydia trachomatis by DNA amplification methods in urine samples from men with urethritis. Int. J. STD AIDS 12:793-796.
30. Tong, C. Y., C. Donnelly, and N. Hood. 1997. Lowering the cut off value of an automated chlamydia enzyme immunoassay and confirmation by PCR and direct immunofluorescent antibody test. J. Clin. Pathol. 50:681-685.
31. Toye, B., R. W. Peeling, P. Jessamine, P. Claman, and I. Gemmill. 1996. Diagnosis of Chlamydia trachomatis infections in asymptomatic men and women by PCR assay. J. Clin. Microbiol. 34:1396-1400.
32. Van Der Pol, B., D. V. Ferrero, L. Buck-Barrington, E. Hook III, C. Lenderman, T. Quinn, C. A. Gaydos, J. Lovchik, J. Schachter, J. Moncada, G. Hall, M. J. Tuohy, and R. B. Jones. 2001. Multicenter evaluation of the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J. Clin. Microbiol. 39:1008-1016.
33. Van Der Pol, B., T. C. Quinn, C. A. Gaydos, K. Crotchfelt, J. Schachter, J. Moncada, D. Jungkind, D. H. Martin, B. Turner, C. Peyton, and R. B. Jones. 2000. Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J. Clin. Microbiol. 38:1105-1112.
34. van Valkengoed, I. G., A. J. Boeke, A. J. van den Brule, S. A. Morre, J. H. Dekker, C. J. Meijer, and J. T. van Eijk. 1999. Systematic home screening for Chlamydia trachomatis infections of asymptomatic men and women in family practice by means of mail-in urine samples. Ned. Tijdsch. Geneeskd. 143:672-676.
35. Watson, E. J., A. Templeton, I. Russell, J. Paavonen, P. A. Mardh, A. Stary, and B. S. Pederson. 2002. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J. Med. Microbiol. 51:1021-1031.
36. Winter, A. J., G. Gilleran, K. Eastick, and J. D. Ross. 2000. Comparison of a ligase chain reaction-based assay and cell culture for detection of pharyngeal carriage of Chlamydia trachomatis. J. Clin. Microbiol. 38:3502-3504.
37. Zenilman, J. M., W. C. Miller, C. Gaydos, S. M. Rogers, and C. F. Turner. 2003. LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value. Sex. Transm. Infect. 79:94-97.